This review comprehensively summarizes CXCL12-CXCR4/CXCR7 signaling axis in cancer progression and provides theoretical basis for the potential of CXCL12 and its receptors CXCR4/CXCR7 as cancer therapeutic targets. This evidence concerns the gene CXCR4 and cancer.